Topics

Human medicines European public assessment report (EPAR): Lysodren, mitotane, Adrenal Cortex Neoplasms, Date of authorisation: 28/04/2004, Revision: 15, Status: Authorised

10:35 EDT 26 Mar 2020 | European Medicines Agency

Human medicines European public assessment report (EPAR): Lysodren, mitotane, Adrenal Cortex Neoplasms, Date of authorisation: 28/04/2004, Revision: 15, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Lysodren, mitotane, Adrenal Cortex Neoplasms, Date of authorisation: 28/04/2004, Revision: 15, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Lysodren, mitotane, Adrenal Cortex Neoplasms, Date of authorisation: 28/04/2004, Revision: 15, Status: Authorised"

Quick Search